The researchers state that there is no existing proof that electric vehicles might disrupt the functions of the so-called implantable cardioverter defibrillators (ICDs) devices like pacemakers.
At the annual meeting of the American College of Cardiology, held last week in San Francisco, scientists identified possible problems that could be associated with increased interest in hybrid cars.
The current study, led by cardiologist Dr. Luis R Scott, evaluated the performance of different ICDs in a Toyota Prius hybrid. The team tested the response of the implants at different driving speed, as well as during acceleration and steady speed.
To assess whether electric vehicles could interfere with pacemakers, the team gathered thirty subjects with heart implants. Their response was monitored ат changing speeds and positions in the car.
The conclusions show that the 2012 Toyota Prius does not present a threat to passengers with ICDs. However, the scientists show that the results can be strengthened by conducting the same tests on different car models.
The study was awarded with honours at the ACC meeting.